{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:47:05Z","timestamp":1789638425251,"version":"4.0.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["ZIA DA000069"],"award-info":[{"award-number":["ZIA DA000069"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["ZIA DA000424"],"award-info":[{"award-number":["ZIA DA000424"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000606"],"award-info":[{"award-number":["Z1A DA000606"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["ZIA DA000493"],"award-info":[{"award-number":["ZIA DA000493"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Department of Health","doi-asserted-by":"publisher","award":["2021-SGR-00230"],"award-info":[{"award-number":["2021-SGR-00230"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["PID2022\\u2013140912OB-I00"],"award-info":[{"award-number":["PID2022\\u2013140912OB-I00"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["PID2023\\u2013146914OB-I00"],"award-info":[{"award-number":["PID2023\\u2013146914OB-I00"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006433","name":"Barcelona Supercomputing Center","doi-asserted-by":"publisher","award":["RES-BCV-2024\\u20132\\u20130002"],"award-info":[{"award-number":["RES-BCV-2024\\u20132\\u20130002"]}],"id":[{"id":"10.13039\/501100006433","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.phrs.2025.107826","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T02:31:07Z","timestamp":1749868267000},"page":"107826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Locomotor activity depends on \u03b2-arrestin recruitment by the dopamine D1 receptor in the striatal D1-D3 receptor heteromer"],"prefix":"10.1016","volume":"218","author":[{"given":"Alexandra H.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ciruela-Jard\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley M.","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie R.","family":"Levinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bonifazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley N.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil","family":"Casajuana-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-Sheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicent","family":"Casad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Earley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy H.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Michaelides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107826_bib1","series-title":"The Rat Nervous System","first-page":"445","article-title":"Basal ganglia","author":"Gerfen","year":"2004"},{"key":"10.1016\/j.phrs.2025.107826_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2025.107826_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1523\/JNEUROSCI.14-01-00088.1994","article-title":"Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets","volume":"14","author":"Sesack","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107826_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1471-4159.2003.02050.x","article-title":"Presynaptic regulation of dopaminergic neurotransmission","volume":"87","author":"Schmitz","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2025.107826_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nn.2862","article-title":"Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors","volume":"14","author":"Bello","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2025.107826_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1073\/pnas.1717194115","article-title":"Differential regulation of striatal motor behavior and related cellular responses by dopamine D2L and D2S isoforms","volume":"115","author":"Radl","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2025.107826_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107826_bib8","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1523\/JNEUROSCI.20-23-08677.2000","article-title":"Dopamine D3 receptors expressed by all mesencephalic dopamine neurons","volume":"20","author":"Diaz","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107826_bib9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.biopsych.2024.05.020","article-title":"Presynaptic and postsynaptic mesolimbic dopamine D3 receptors play distinct roles in cocaine versus opioid reward in mice","volume":"96","author":"Xi","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107826_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/jn.2001.85.2.659","article-title":"Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice","volume":"85","author":"Cepeda","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.phrs.2025.107826_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601631","article-title":"Key role of the dopamine D4 receptor in the modulation of corticostriatal glutamatergic neurotransmission","volume":"3","author":"Bonaventura","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2025.107826_bib12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.25104","article-title":"Targeting hypersensitive corticostriatal terminals in restless legs syndrome","volume":"82","author":"Yepes","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2025.107826_bib13","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1523\/JNEUROSCI.16-20-06579.1996","article-title":"Coordinated expression of dopamine receptors in neostriatal medium spiny neurons","volume":"16","author":"Surmeier","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107826_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0165-0173(97)00046-5","article-title":"Functional implications of multiple dopamine receptor subtypes: the D1\/D3 receptor coexistence, Brain Res","volume":"26","author":"Schwartz","year":"1998","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.phrs.2025.107826_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106476","article-title":"Pharmacological targeting of G protein-coupled receptor heteromers","volume":"185","author":"Moreno","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2025.107826_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","article-title":"Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons","volume":"20","author":"Gurevich","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2025.107826_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/mol.107.043885","article-title":"Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization","volume":"74","author":"Fiorentini","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib18","doi-asserted-by":"crossref","first-page":"26016","DOI":"10.1074\/jbc.M710349200","article-title":"Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum","volume":"283","author":"Marcellino","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.107826_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/mol.114.093096","article-title":"Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer","volume":"86","author":"Guitart","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1021\/cb5007568","article-title":"Time-resolved FRET binding assay to investigate hetero-oligomer binding properties: proof of concept with dopamine D1\/D3 heterodimer","volume":"10","author":"Hounsou","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.phrs.2025.107826_bib21","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s12035-014-8936-x","article-title":"Stronger dopamine D1 receptor-mediated neurotransmission in dyskinesia","volume":"52","author":"Farr\u00e9","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107826_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-2999(94)90099-X","article-title":"Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors","volume":"255","author":"Ferr\u00e9","year":"1994","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/WNL.33.11.1489","article-title":"Behavioral correlations of dopamine receptor activation","volume":"33","author":"Gershanik","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2025.107826_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(85)90345-0","article-title":"Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats","volume":"113","author":"Arnt","year":"1985","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(86)90588-1","article-title":"Obligatory D-1\/D-2 receptor interaction in the generation of dopamine agonist related behaviors","volume":"131","author":"Braun","year":"1986","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0028-3908(87)90155-9","article-title":"Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice","volume":"26","author":"Starr","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107826_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(89)90831-7","article-title":"Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats","volume":"487","author":"Dreher","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2025.107826_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jsmc.2021.02.012","article-title":"Akathisia and restless legs syndrome: solving the dopaminergic paradox","volume":"16","author":"Ferre","year":"2021","journal-title":"Sleep. Med. Clin."},{"key":"10.1016\/j.phrs.2025.107826_bib29","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0022-3565(25)12192-7","article-title":"Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907","volume":"275","author":"Pugsley","year":"1995","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.phrs.2025.107826_bib30","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1021\/acs.jmedchem.9b00702","article-title":"The significance of chirality in drug design and synthesis of bitopic ligands as D3 receptor (D3R) selective agonists","volume":"62","author":"Battiti","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2025.107826_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF01300133","article-title":"Antagonism by haloperidol of locomotor depression induced by small doses of apomorphine","volume":"40","author":"Str\u00f6mbom","year":"1977","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.phrs.2025.107826_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00167035","article-title":"Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function","volume":"340","author":"Jackson","year":"1989","journal-title":"A Behav. Biochem. Study Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01258632","article-title":"Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists","volume":"75","author":"Jackson","year":"1989","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.phrs.2025.107826_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0028-3908(93)90177-5","article-title":"Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other \u201cD-2-like\u201d agonists","volume":"32","author":"Daly","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107826_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02246662","article-title":"Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine","volume":"124","author":"Depoortere","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2025.107826_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(95)00063-Q","article-title":"Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors","volume":"277","author":"Starr","year":"1995","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/sj.npp.1300018","article-title":"7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment","volume":"28","author":"Pritchard","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2025.107826_bib38","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0028-3908(99)00064-7","article-title":"Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2\/D3 receptor agonists","volume":"38","author":"Boulay","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107826_bib39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0028-3908(98)00213-5","article-title":"Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice","volume":"38","author":"Boulay","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107826_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuropharm.2004.09.003","article-title":"Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels","volume":"48","author":"Zapata","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107826_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/FBP.0b013e32833a5c68","article-title":"Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats","volume":"21","author":"Li","year":"2010","journal-title":"Behav. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib42","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1007\/s12035-019-1564-8","article-title":"Biased G protein-independent signaling of dopamine D1-D3 receptor heteromers in the nucleus accumbens","volume":"56","author":"Guitart","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107826_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/mol.115.101808","article-title":"Evidence for noncanonical neurotransmitter activation: norepinephrine as a dopamine D2-like receptor agonist","volume":"89","author":"Sanchez-Soto","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib44","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s12035-018-1120-y","article-title":"Adenosine A1-dopamine D1 receptor heteromers control the excitability of the spinal motoneuron","volume":"56","author":"Rivera-Oliver","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107826_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuron.2010.12.001","article-title":"Facilitation of mu-opioid receptor activity by preventing delta-opioid receptor-mediated codegradation","volume":"69","author":"He","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107826_bib46","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/s41467-018-03522-3","article-title":"Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase","volume":"9","author":"Navarro","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107826_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0306-4522(87)90208-9","article-title":"Behavioural role of dopamine D1 receptors in the reserpine-treated mouse","volume":"22","author":"Starr","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107826_bib48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/biom11040570","article-title":"Chirality of novel bitopic agonists determines unique pharmacology at the dopamine D3 receptor","volume":"11","author":"Adhikari","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2025.107826_bib49","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1021\/acs.jmedchem.6b00860","article-title":"Highly selective dopamine D3 receptor (D3R) antagonists and partial agonists based on eticlopride and the d3r crystal structure: new leads for opioid dependence treatment","volume":"59","author":"Kumar","year":"2016","journal-title":"J. Med Chem."},{"key":"10.1016\/j.phrs.2025.107826_bib50","first-page":"839","article-title":"Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor, J Me","volume":"48","author":"Grundt","year":"2005","journal-title":"D. Chem."},{"key":"10.1016\/j.phrs.2025.107826_bib51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1748-1716.1988.tb08490.x","article-title":"Stimulation of D1 dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors","volume":"134","author":"And\u00e9n","year":"1988","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.phrs.2025.107826_bib52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nsmb.2504","article-title":"Crystal structure of oligomeric \u03b21-adrenergic G protein-coupled receptors in ligand-free basal state","volume":"20","author":"Huang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.phrs.2025.107826_bib53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the \u00b5-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107826_bib54","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1126\/science.1197410","article-title":"Structure of the human dopamine D3 receptor in complex with a D2\/D3 selective antagonist","volume":"330","author":"Chien","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107826_bib55","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.molcel.2021.01.003","article-title":"Structures of the human dopamine D3 receptor-Gi complexes","volume":"81","author":"Xu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.107826_bib56","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1038\/s41467-022-30929-w","article-title":"Ligand recognition and biased agonism of the D1 dopamine receptor","volume":"13","author":"Teng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107826_bib57","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1016\/j.neuron.2022.08.006","article-title":"Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD","volume":"110","author":"Cao","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107826_bib58","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jmb.2007.09.078","article-title":"Crystal structures of the luciferase and green fluorescent protein from Renilla reniformis","volume":"374","author":"Loening","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.phrs.2025.107826_bib59","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107826_bib60","unstructured":"J. Chai Discovery, J. Boitreaud, M. Dent, J. McPartlon, V. Meier, A. Reis, K. RogozhnikovChai-1: Decoding the molecular interactions of life2024, http:\/\/10.1101\/2024.10.10.615955."},{"key":"10.1016\/j.phrs.2025.107826_bib61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0026-895X(25)08874-1","article-title":"Specific antibodies against Go isoforms reveal the early expression of the Go2 alpha subunit and appearance of Go1 alpha during neuronal differentiation","volume":"41","author":"Rouot","year":"1992","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib62","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1073\/pnas.83.7.2258","article-title":"Use of specific antibodies to quantitate the guanine nucleotide-binding protein Go in brain","volume":"83","author":"Gierschik","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107826_bib63","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1124\/mol.119.115956","article-title":"A biased view of \u03bc-opioid receptors?","volume":"96","author":"Conibear","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib64","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/mol.119.119214","article-title":"Intrinsic efficacy of opioid ligands and its importance for apparent bias, operational analysis, and therapeutic window","volume":"98","author":"Gillis","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107977","article-title":"G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)","volume":"231","author":"Ferre","year":"2022","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2025.107826_bib66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tips.2015.01.002","article-title":"The GPCR heterotetramer: challenging classical pharmacology","volume":"36","author":"Ferre","year":"2015","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.phrs.2025.107826_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106322","article-title":"Preferential Gs protein coupling of the galanin Gal1 receptor in the micro-opioid-Gal1 receptor heterotetramer","volume":"182","author":"De Oliveira","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2025.107826_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02246952","article-title":"Biphasic locomotor effects of the dopamine D1 agonist SKF 38393 and their attenuation in non-habituated mice","volume":"110","author":"Tirelli","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2025.107826_bib69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0091-3057(87)90485-0","article-title":"Effects of systemic and intracranial amphetamine injections on behavior in the open field: a detailed analysis","volume":"27","author":"Carr","year":"1987","journal-title":"Pharm. Biochem. Behav."},{"key":"10.1016\/j.phrs.2025.107826_bib70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0166-4328(89)80005-1","article-title":"Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior","volume":"35","author":"Kelley","year":"1989","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2025.107826_bib71","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF00589908","article-title":"Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity","volume":"99","author":"Plaznik","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2025.107826_bib72","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1523\/JNEUROSCI.10-01-00303.1990","article-title":"Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat","volume":"10","author":"Delfs","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107826_bib73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0306-4522(90)90221-O","article-title":"The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum","volume":"39","author":"Delfs","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107826_bib74","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0306-4522(02)00247-6","article-title":"Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1\/D2 agonists","volume":"113","author":"Ikemoto","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107826_bib75","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-8993(75)90233-4","article-title":"Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum","volume":"94","author":"Kelly","year":"1975","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2025.107826_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(76)90352-6","article-title":"Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats","volume":"40","author":"Kelly","year":"1976","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107826_bib77","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.celrep.2016.06.098","article-title":"\u03b2-arrestin-dependent dopaminergic regulation of calcium channel activity in the axon initial segment","volume":"16","author":"Yang","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2025.107826_bib78","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopsych.2023.03.006","article-title":"Arrestin-3 agonism at dopamine D3 receptors defines a subclass of second-generation antipsychotics that promotes drug tolerance","volume":"94","author":"Schamiloglu","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107826_bib79","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1523\/JNEUROSCI.0310-17.2017","article-title":"D3 receptors regulate excitability in a unique class of prefrontal pyramidal cells","volume":"37","author":"Clarkson","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107826_bib80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/bs.pmbts.2019.11.006","article-title":"Oligomerization of G protein-coupled receptors: Still doubted?","volume":"169","author":"Ferre","year":"2020","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.phrs.2025.107826_bib81","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.113.008052","article-title":"G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives","volume":"66","author":"Ferre","year":"2014","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.phrs.2025.107826_bib82","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03495-2","article-title":"Structures of Gi-bound metabotropic glutamate receptors mGlu2 and mGlu4","volume":"594","author":"Lin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107826_bib83","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-021-03507-1","article-title":"Structural basis of GABAB receptor-Gi protein coupling","volume":"594","author":"Shen","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107826_bib84","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41594-022-00797-5","article-title":"Structural insight into apelin receptor-G protein stoichiometry","volume":"29","author":"Yue","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.phrs.2025.107826_bib85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12915-020-0739-0","article-title":"Control of glutamate release by complexes of adenosine and cannabinoid receptors","volume":"18","author":"Kofalvi","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.phrs.2025.107826_bib86","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cell.2016.07.004","article-title":"GPCR-G protein-\u03b2-arrestin super-complex mediates sustained G protein signaling","volume":"166","author":"Thomsen","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.107826_bib87","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1124\/jpet.121.001045","article-title":"Role of efficacy as a determinant of locomotor activation by Mu opioid receptor ligands in female and male mice","volume":"382","author":"Santos","year":"2022","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.phrs.2025.107826_bib88","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMcp021288","article-title":"Clinical practice. Restless legs syndrome","volume":"348","author":"Earley","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2025.107826_bib89","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/WNL.0b013e3182242d91","article-title":"Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome","volume":"77","author":"Manconi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2025.107826_bib90","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.sleep.2014.05.009","article-title":"Altered Brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis\u2013Ekbom Disease)","volume":"15","author":"Earley","year":"2014","journal-title":"Sleep. Med."},{"key":"10.1016\/j.phrs.2025.107826_bib91","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1073858418791763","article-title":"New insights into the neurobiology of restless legs syndrome","volume":"25","author":"Ferre","year":"2019","journal-title":"Neuroscientist"},{"key":"10.1016\/j.phrs.2025.107826_bib92","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","article-title":"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa","volume":"94","author":"Bordet","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107826_bib93","first-page":"435","article-title":"Dopamine D3 receptor modulates l-DOPA-induced dyskinesia by targeting D1 receptor-mediated striatal signaling","volume":"27","author":"Sol\u00eds","year":"2017","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.phrs.2025.107826_bib94","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2018.06.024","article-title":"Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: implications for L-DOPA-induced dyskinesia","volume":"138","author":"Lanza","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107826_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113534","article-title":"Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia","volume":"336","author":"Lanza","year":"2021","journal-title":"Exp. Neurol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825002518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825002518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T14:22:57Z","timestamp":1753712577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825002518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":95,"alternative-id":["S1043661825002518"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107826","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Locomotor activity depends on \u03b2-arrestin recruitment by the dopamine D1 receptor in the striatal D1-D3 receptor heteromer","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107826"}}